Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Multiple Sclerosis, Date of authorisation: 30/01/2014, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Omnitrope, somatropin, Turner Syndrome;Prader-Willi Syndrome;Dwarfism, Pituitary, Date of authorisation: 12/04/2006, Revision: 22, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Rozanolixizumab, decision type: , therapeutic area: , PIP number: P/0410/2022

Opinion/decision on a Paediatric investigation plan (PIP): Vumerity,Diroximel fumarate (BIIB098), decision type: , therapeutic area: , PIP number: P/0413/2022

Opinion/decision on a Paediatric investigation plan (PIP): Zoliflodacin, decision type: , therapeutic area: , PIP number: P/0381/2022

Opinion/decision on a Paediatric investigation plan (PIP): Xofluza,Baloxavir marboxil, decision type: , therapeutic area: , PIP number: P/0383/2022

Medicinal products for human use: monthly figures - August 2023

Calcium chloride dihydrate/magnesium chloride hexahydrate/malic acid/sodium acetate trihydrate/sodium chloride....potassium chloride : List of nationally authorised medicinal products - PSUSA/00010622/202301

Opinion/decision on a Paediatric investigation plan (PIP): Bismuth (subcitrate),Metronidazole (benzoate),Tetracycline (hydrochloride), decision type: , therapeutic area: , PIP number: P/0371/2022